Skip Standard Navigation Links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
peer-reviewed.gif (582 bytes)
eid_header.gif (2942 bytes)
second_navbar.gif (585 bytes)
Past Issue

Vol. 7, No. 4
Jul–Aug 2001

Download Article
PDF
Help
Feedback


 
Letter

Enteric Fever Treatment Failures—Reply to Drs. Chandel and Chaudhry

Read D. Chandel and R. Chaudhry letter, http://www.cdc.gov/ncidod/eid/vol7no4/chaudhry_letter.htm

Read original article, http://www.cdc.gov/ncidod/eid/vol7no3/threlfall.htm

To the Editor: We are pleased that Drs. Chandel and Chaudhry support our concern that the development of low-level resistance to fluoroquinolone antimicrobial agents in Salmonella enterica serotype Typhi is a threat to health in both developing and developed countries. They cite their article (1) reporting the recent emergence in India of strains of S. Paratyphi A resistant to nalidixic acid and with low-level resistance to ciprofloxacin. This finding has also been observed in the United Kingdom, with >30% of S. Paratyphi A infections in 2000 being caused by strains with decreased susceptibility to ciprofloxacin. Of these strains, only one was also resistant to other antimicrobial agents.

Our findings and those of Chandel and Chaudhry clearly demonstrate the inadvisability of the use of ciprofloxacin in the Indian Subcontinent to treat many human infections, regardless of prescription. To maintain the efficacy of fluoroquinolones in both developing and developed countries, this class of antimicrobial agents must be reserved for treatment of invasive disease and not for prophylaxis. For travelers visiting developing countries, ciprofloxacin must be used only when absolutely necessary and not for treatment of uncomplicated gastroenteritis or for travelers' diarrhea syndromes.

E. John Threlfall and Linda R. Ward
Central Public Health Laboratory, London, United Kingdom

Reference

  1. Chandel DS, Chaudhry R, Dhawan B, Pandey A, Dey AB. Drug-resistant Salmonella enterica serotype Paratyphi A in India. Emerg Infect Dis 2000;6:420-1.

Comments to the EID Editors
Please use this form to submit comments to the EID Editors.

Email (optional)


Home | Top of Page | Current Issue | Expedited | Upcoming Issue | Past Issue | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | Search | Health Topics A-Z

This page last reviewed December 08, 2001

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention